Health

Purple Pixie Healthcare expands Dr ToothLittle to 10 clinics in Bengaluru; targets 15 centres by FY28
Purple Pixie Healthcare expands Dr ToothLittle to 10 clinics in Bengaluru; targets 15 centres by FY28

India’s first exclusive paediatric oral healthcare clinic chain plans foray into other South Indian cities to address a gaping need in paediatric oral healthcare

Bengaluru (Karnataka) [India], October 15: Purple Pixie Healthcare, parent company of Dr ToothLittle, India’s first exclusive paediatric oral healthcare clinic chain, today announced the expansion of its network to 10 clinics across Bengaluru city, strengthening its position as one of the country’s pioneering organised players, focused exclusively on paediatric oral healthcare.

The company plans to take the Dr ToothLittle network to 15 clinics in Bengaluru by FY 2027-28, after which it looks to foray into other key cities in South India. The expansion represents nearly two decades of pioneering work by Dr Premila Naidu, Founder & MD of Purple Pixie Healthcare. Through Dr ToothLittle, Dr Naidu has paved the way in transforming paediatric dentistry from a predominantly treatment-led service to a specialised, experience-driven model of healthcare, integrating clinical excellence with behavioural science, child psychology, sensory design and preventive care.

The expansion comes against the backdrop of a significant and growing opportunity in paediatric oral health in India. Industry estimates project India’s paediatric oral care market to reach approximately US$1.71 billion by 2030, growing at a compound annual growth rate of 8% between 2025 and 2030.  Bengaluru-specific clinical studies have found dental caries in 27.5% of preschool children aged 8–48 months, based on a study of 1,500 children. A separate study of 1,452 school children aged 12–15 years found a caries prevalence of 57.9%, with 19.4% experiencing untreated dental caries with clinical consequences. These findings underscore the scale of childhood dental disease and the need for greater emphasis on early intervention, preventive care and specialised treatment.

Speaking on the milestone, Dr. Premila Naidu, Founder & Managing Director, Purple Pixie Healthcare and CEO, Dr ToothLittle, said: “When we started in 2007, the idea of creating a dedicated dental ecosystem exclusively for children was considered unconventional. We believed children deserved more than treatment; they deserved an experience that removed fear, built trust and encouraged lifelong oral health habits. Every decision we have made since then has been guided by that belief.”

“Reaching ten centres is an important milestone, but more importantly, it validates the need for a specialised approach to paediatric oral healthcare. India has a very large child population and a significant burden of dental disease, yet specialised, child-centric oral healthcare remains relatively underdeveloped. We see an opportunity to build a much larger ecosystem around prevention, early intervention and positive oral-health behaviours, not simply treatment.”

For Purple Pixie Healthcare, this gap between high disease prevalence, a large paediatric population and limited access to specialised child-centric dental care, represents both a significant healthcare need and an opportunity to build a differentiated, organised-care category. Purple Pixie’s next phase of growth will focus on creating a larger footprint, while retaining the clinical and experiential standards that define the Dr ToothLittle model.

Dr ToothLittle is at present supported by a team of 26 specialised paediatric dentists and child healthcare-trained staff and has built a 70% patient return rate, reflecting sustained trust among families and the long-term relationships developed with its young patients.

About Purple Pixie Healthcare

Purple Pixie Healthcare is a specialised paediatric healthcare company focused on building innovative, child-centric oral healthcare solutions that combine clinical excellence, behavioural science, design thinking and preventive care. Its flagship brand, Dr ToothLittle, is India’s first multi-sensory dental clinic chain exclusively for children. Founded in 2007 by Dr. Premila Naidu, the network today operates 10 centres across Bengaluru and has earned the trust of thousands of families through its differentiated child-first model of care.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Festive Travel, Long Garba Nights & Less Water: 5 Ways to Protect Your Urinary Health This October
Festive Travel, Long Garba Nights & Less Water: 5 Ways to Protect Your Urinary Health This October
ToothLens Expands Across Plum, Loop, Pazcare, and Onsurity as Dental Emerges as a New Frontier in Employee Health Insurance
ToothLens Expands Across Plum, Loop, Pazcare, and Onsurity as Dental Emerges as a New Frontier in Employee Health Insurance
FREOSSI Wound Healing Spray with Curcumin: Supporting Everyday Wound Care for Pets
FREOSSI Wound Healing Spray with Curcumin: Supporting Everyday Wound Care for Pets

Business

Lagnam Spintex Reports Strong Q2 & H1 Fy27 Performance; Ebitda Rises 98% In Q2 And 64% In H1fy27
Lagnam Spintex Reports Strong Q2 & H1 Fy27 Performance; Ebitda Rises 98% In Q2 And 64% In H1fy27

New Delhi [India], October 17: Lagnam Spintex Limited, a leading textile High Quality Cotton Yarn manufacturing company, announced its unaudited financial results for the quarter and half year ended September 30, 2026, reporting a strong improvement in revenue, operating profitability and bottom-line performance.

Q2FY27 Key Financial Highlights

“Revenue +30% | EBITDA +98% | PBDT +249% | PAT +2053%”

H1FY27 Key Financial Highlights:

“Revenue +24% | EBITDA +64% | PBDT +153%  | PAT +499% ”

The Company delivered a robust performance during Q2FY27, with Revenue from Operations increasing 30.3% year-on-year to ₹172.59 crore, compared with ₹132.43 crore in Q2FY26. The strong revenue growth was accompanied by significant operating leverage, with EBITDA almost doubling to ₹23.66 crore, compared with ₹11.94 crore in the corresponding quarter of the previous year.

Q2FY27 – Key Financial Highlights:

Particulars Q2FY27 Q2FY26 YoY Growth
Revenue from Operations ₹172.59 Cr ₹132.43 Cr +30%
EBITDA ₹23.66 Cr ₹11.94 Cr +98%
PBDT ₹16.12 Cr ₹4.62 Cr +249%
PAT ₹8.18 Cr ₹0.38 Cr +2053%
EPS ₹4.63 ₹0.21 +22 Times

Strong improvement in operating margins:

EBITDA margin expanded substantially to 13.71% in Q2FY27, compared with 9.02% in Q2FY26.

Profit After Tax (PAT) surged to ₹8.18 crore, compared with ₹0.38 crore in the corresponding quarter of the previous year — a growth of more than 20 times.

EPS increased to ₹4.63 in Q2FY27, compared with ₹0.21 in Q2FY26, reflecting the significant improvement in profitability.

H1FY27 performance demonstrates strong earnings momentum

Lagnam Spintex recorded Revenue from Operations of ₹338.44 crore, registering a growth of 24.2% over ₹272.53 crore in H1 FY26.

The improvement in profitability was even stronger, with EBITDA increasing 64.4% to ₹44.44 crore, compared with ₹27.03 crore in H1FY26. EBITDA margin consequently expanded to 13.13% from 9.92%.

Profit After Tax increased nearly six-fold to ₹14.07 crore, compared with ₹2.35 crore in the corresponding period last year.

EPS for H1 FY27 stood at ₹7.96, compared with ₹1.33 in H1 FY26.

Domestic business continues to drive growth

Amid ongoing global business disruptions, the Company’s Domestic revenue for Q2FY27 increased by approximately 42% to ₹111.37 crore, compared with ₹78.29 crore in Q2FY26 supported by robust demand and improved margins in the domestic market.

For H1FY27, domestic revenue increased to ₹232.93 crore from ₹147.64 crore, registering a strong growth of approximately 58%.

H1FY27 – Key Financial Highlights:

Particulars H1 FY27 H1 FY26 YoY Growth
Revenue from Operations ₹338.44 Cr ₹272.53 Cr 24%
EBITDA ₹44.44 Cr ₹27.03 Cr 64%
PBDT ₹29.17 Cr ₹11.53 Cr 153%
PAT ₹14.07 Cr ₹2.35 Cr 499%
EPS ₹7.96 ₹1.33 +5.98 Times

Commenting on the performance, Mr. Anand Mangal- Managing Director, said:

“We are pleased to announce the strong performance delivered during the second quarter and first half of FY27. The growth in revenue, coupled with a significant improvement in EBITDA margins, reflects the Company’s continued focus on operational efficiency, product mix and profitable growth.

The strong growth in our domestic business has been an important contributor to the overall performance, while our export business continues to remain an integral part of our diversified market strategy.

The Company is expected to commission shortly approximately 15.5 MW renewable energy projects. Upon commissioning, approximately 70% of its total energy requirements will be met through its renewable sources, representing a significant milestone in its sustainability journey while supporting long-term operational efficiency and cost optimisation.

Going forward, our focus will remain on strengthening operational efficiencies, improving profitability, maintaining a healthy balance between domestic and export markets, and creating sustainable long-term value for our stakeholders.”

Celebrating 20 Years of Pioneering India’s Solar Revolution: Orb Energy’s Journey
Celebrating 20 Years of Pioneering India’s Solar Revolution: Orb Energy’s Journey
As India’s Top Law Firms Embrace AI, VakilPlus Wants to Bring It to Every Lawyer
As India’s Top Law Firms Embrace AI, VakilPlus Wants to Bring It to Every Lawyer
Onward Technologies Delivers its Strongest-Ever Quarter; Total Revenue up 22.2% and EBITDA up 33.7% YoY; Raises FY27 Outlook
Onward Technologies Delivers its Strongest-Ever Quarter; Total Revenue up 22.2% and EBITDA up 33.7% YoY; Raises FY27 Outlook